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Abstract
Introduction: Better characterization of the relationship between episodic memory and hippocampal volumes is
crucial in early detection of neurodegenerative disease. We examined these relationships in a memory clinic population.
Methods: Participants (n = 226) underwent structural magnetic resonance imaging and tests of verbal (Hopkins Verbal
Learning Test-Revised, HVLT-R) and non-verbal (Brief Visuospatial Memory Test-Revised, BVMT-R) memory. Correlational
analyses were performed, and analyses on clinical subgroups (i.e., amnestic Mild Cognitive Impairment, non-amnestic
Mild Cognitive Impairment, probable Alzheimer’s disease, intact memory) were conducted.
Results: Positive associations were identified between bilateral hippocampal volumes and both memory measures, and
BVMT-R learning slope was more strongly positively associated with hippocampal volumes than HVLT-R learning slope.
Amnestic Mild Cognitive Impairment (aMCI) participants showed specific positive associations between BVMT-R
performance and hippocampal volumes bilaterally. Additionally, analyses of the aMCI group showed trend-level evidence
of material-specific lateralization, such that retention of verbal information was positively associated with left hippocampal
volume, whereas learning curve and retention of non-verbal information was positively associated with right
hippocampal volume.
Conclusions: Findings support the link between episodic memory and hippocampal volumes in a memory clinic
population. Non-verbal memory measures also may have higher diagnostic value, particularly in individuals at elevated
risk for Alzheimer’s disease.
Introduction
Medial temporal lobe (MTL) structures (e.g., hippo-
campus) are integral to the formation of new memories
and are centrally related to development of Alzheimer’s
disease (AD) [1]. Specifically, MTL atrophy and associated
episodic memory impairment are hallmark features of AD,
and both progressively decline over the course of the
disease [2, 3].
Material-specific lateralization of brain function is a
classic neurological and neuropsychological finding [4].
Lesion and functional neuroimaging studies have found
that memory function is lateralized based on material
type [5] (see [6] for review). In general, left hemisphere
structures (including left hippocampus) are implicated in
verbal memory processing [7], while right hemisphere
structures (including right hippocampus) support non-
verbal/spatial memory [8].
Additionally, some previous work using various neuro-
imaging methodologies (e.g., voxel-based morphometry)
suggests positive associations between hippocampal size
and memory performance [9–12], including in patients
with AD [13–21]. However, there is significant variability
among older adults with regard to this relationship, with
some groups finding no evidence of an association [22]
(see [23] for review). Better characterization of the rela-
tionship between commonly used episodic memory mea-
sures and hippocampal volumes is crucial, as it may assist
in efforts at early detection of neurodegenerative disease
and may suggest new biomarkers for use in clinical trials
of AD therapies.
Previous studies in this area have had limitations. De
Toledo-Morrell et al. [24] examined the relationship
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between hippocampal volumes and verbal vs. non-verbal
memory processing in individuals with probable AD and
healthy older adults. They found that left hippocampal
volume was the strongest predictor of verbal memory,
whereas right hippocampal volume was the strongest pre-
dictor of spatial memory. Similar findings were reported
by Kohler and colleagues [15] in individuals with AD.
However, our study has various advantages over previous
work that allow for more accurate acquisition and seg-
mentation of brain images and better characterization of
memory performance. For example, Kohler and colleagues
used a 1.5T Signa system with a standard head coil to ac-
quire brain images. Volumes of interest were determined
using ANALYZE software, and manual tracing ("planim-
etry") was used to delineate the hippocampus. In contrast,
our study used fully automated FDA-approved software
for hippocampal segmentation. We used the Alzheimer's
Disease Neuroimaging Initiative (ADNI) sequence, and 3
Tesla MRI scanners were utilized for imaging in all sub-
jects. Furthermore, most previous studies have lacked
inclusion of other groups of interest, including individuals
with Mild Cognitive Impairment (MCI) who are at ele-
vated risk for development of AD. This is a particularly
crucial point, as the AD disease process is hypothesized to
begin years before symptom onset, and evidence of signifi-
cant MTL atrophy has been found even in those at the
MCI stage [25, 26].
Although verbal memory tasks often have been more
commonly utilized (e.g., [19, 27, 28], there is increasing
support for the role of non-verbal memory tasks in
dementia assessment. Various studies (i.e., [29, 30] have
reported that rate of learning on non-verbal memory
measures has better diagnostic value than verbal mem-
ory measures and can discriminate individuals at various
stages (i.e., controls vs. MCI vs. mild AD). Okonkwo et
al. [31] found that non-verbal learning and delayed recall
performance among cognitively-intact older adults sig-
nificantly dissociated individuals who showed cognitive
decline over a follow-up period from those who
remained cognitively stable. Others have found that vis-
ual, rather than verbal, memory measures were predict-
ive of memory decline and development of AD [32, 33].
As such, further examination of the relative merits and
predictive value of these measures is warranted, particu-
larly as they relate to volumes of the hippocampus.
The current study examined the relationships between
hippocampal volumes (as measured by NeuroQuant soft-
ware) and performance on two analogous measures of
verbal and non-verbal episodic memory (i.e., Hopkins Ver-
bal Learning Test-Revised [34], Brief Visuospatial Memory
Test-Revised [35]) in a sample of memory clinic patients.
We had three objectives: 1) explore whether episodic
memory performance is related to hippocampal volumes
in our sample; 2) determine whether associations are
lateralized in a material-specific manner (i.e., verbal mem-
ory performance more strongly related to left hippocam-
pal volume, non-verbal memory performance more
strongly related to right hippocampal volume); and 3)
examine these relationships in diagnostic groups of inter-
est who may be at higher risk for development of demen-
tia (i.e., amnestic MCI). We predicted significant positive
relationships between hippocampal volumes and memory
measures for the whole sample, as well as material-
specific lateralization of relationships between hippocam-
pal volumes and memory performance. Additionally, we
predicted similar relationships in individuals with amnes-
tic MCI and AD.
Methods
Participants
Archival clinical data were extracted from the elec-
tronic medical records of patients seen for clinical
exams in the Center for Brain Health at the Cleveland
Clinic (Cleveland, OH, and Las Vegas, NV) in accord-
ance with regulations of the Institutional Review Board
of the Cleveland Clinic, and the nature of data collec-
tion indicated that no informed consent was required
of participants. Participants (n = 226) were included in
the study if they had undergone structural magnetic
resonance imaging (MRI) of the brain (for quantifica-
tion of hippocampal volumes) and neuropsychological
evaluation in the course of routine clinical care. Demo-
graphic and descriptive information is presented in Table 1.
Diagnoses were determined through consensus conference
or consultation with the referring physician and included
patients with Alzheimer’s disease (n = 34), Mild Cognitive
Impairment, amnestic type (n = 82), Mild Cognitive Im-
pairment, non-amnestic type (n = 13) and age-associated
memory changes (i.e., normal memory; n = 25). The re-
mainder of the sample (n = 72) consisted of patients with
other neurological disorders typically seen in a dementia
clinic, primarily those with neurodegenerative disorders
(e.g., frontotemporal dementia, primary progressive apha-
sia, corticobasal syndrome, etc.), as well as a small percent-
age diagnosed with stroke or vascular dementia.
Neuropsychological measures
We used performance on two episodic memory measures
as variables of interest: the Hopkins Verbal Learning
Test-Revised (HVLT-R; [34]) and the Brief Visuospatial
Memory Test-Revised (BVMT-R; [35]).
The HVLT-R is a 12-item verbal episodic memory
measure in which words are read aloud over three learn-
ing trials. Following each presentation of the word list, the
participant recites as many words as can be recalled spon-
taneously, and the total number of words recalled over the
three learning trials is recorded (range = 0–36). Following
a 20-minute delay, the participant spontaneously recalls as
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many words as possible. Lastly, a recognition trial is pre-
sented in which the participant is required to discriminate
the previously-presented words from new foil words.
The BVMT-R is a non-verbal episodic memory measure.
Test stimuli consist of six geometric shapes presented
over three learning trials. The participant is presented
with the array of six shapes for 10 seconds each. Following
each of the three learning trials, the participant is asked to
spontaneously reproduce as many shapes as possible. Each
shape is worth a maximum of two points (one point for
correct form, one point for correct location), and total
learning over the three trials is measured (range = 0–36).
Delayed recall and recognition are also measured. The
overall structure of the measure is similar to the HVLT-R,
and the two measures are co-normed.
Structural MRI parameters
Volumetric analysis of the brain was performed on a sep-
arate workstation for all participants following acquisition
of the structural MRI. Software-compatible high reso-
lution T1-weighted anatomical MRI scans were obtained
on all patients, (T1-weighted 3D Sagittal MP-RAGE).
ADNI (Alzheimer's Disease Neuroimaging Initiative)
protocol was utilized for all studies performed starting 7
January 2010. Prior to this date, axial 3-D T1 MPRAGE
was used on a small number of participants included in
this study. Participants were scanned using four scanner
models, all compatible with the analysis software. Acquisi-
tion protocol details are as follows: TR/TE/TI = 2300/
2.98/900, Flip Angle = 9, BW= 240 H z/Px, 240 × 256
matrix, 160 slices, voxel size =1 × 1 × 1.2 mm, scan time:
9:14. The scanners are detailed as follows: A Siemens 3T
Verio scanner with a 12-channel head coil (Siemens
Medical Systems, Erlangen, Germany), Siemens 3T Skyra
scanners with a 16 channel head coil (Siemens Medical
Systems, Erlangen, Germany), Siemens 3T Trio scanners
with a 12 channel head coil (Siemens Medical Systems,
Erlangen, Germany), and a Siemens 1.5T Symphony scan-
ner for patients with any contraindication to 3T scanning.
Following acquisition, images from the ADNI sequence
were sent to the image analysis lab at the Cleveland Clinic
for volumetric analysis. NeuroQuant software (CorTechs
Labs, Inc., San Diego, CA, USA) was used for analysis.
NeuroQuant is a commercially available FDA-approved
software program for measuring brain MRI volume in
clinical settings. Images were sent directly from the scan-
ners to the NeuroQuant server where analysis started
automatically and results were routed automatically to
the Radiology Archives, Cleveland Clinic. Initially, im-
ages were sent to open-source intermediate viewing
software (OsirX), then to the NeuroQuant server.
NeuroQuant analysis involved several automated
steps, including stripping the brain of scalp, skull and
meninges; inflating the brain to a spherical shape;
mapping the spherical brain to a common spherical
space shared with the Talairach Atlas brain [36]; iden-
tification of brain regions; and deflation of the pa-
tient’s brain back to its original shape while retaining
the identifying information for brain segments. The out-
put of the NeuroQuant computer-automated analysis in-
cluded a report containing volumetric information, and a
set of DICOM-formatted brain images that were
Table 1 Demographic and behavioral data
Entire sample aMCI naMCI AD Normal memory
(N = 226) (N = 86) (N = 13) (N = 34) (N = 25)
Age (yrs)a 67.7 (9.1) 67.8 (8.4) 67.7 (6.6) 71.2 (9.8) 63.6 (5.8)
Sex (% female) 57.1 59.8 53.8 58.8 56.0
Education (yrs) 14.5 (2.9) 14.8 (2.7) 13.7 (2.4) 14.7 (3.1) 15.5 (2.9)
Handedness (% right) 89.8 85.4 92.3 91.2 88.0
HVLT-R Learningb 17.2 (6.6) 16.3 (5.3) 21.3 (4.8) 11.7 (4.1) 25.5 (3.3)
HVLT-R Recallc 3.9 (3.8) 2.5 (2.8) 7.2 (2.1) 1.0 (1.7) 9.6 (1.6)
BVMT-R Learningd 11.4 (7.8) 9.7 (5.8) 18.9 (6.4) 5.5 (3.7) 22.0 (4.4)
BVMT-R Recalle 4.1 (3.5) 3.3 (2.9) 7.7 (2.5) 1.5 (1.8) 8.8 (1.9)
R Hippocampus (cm3)f 3.7 (0.6) 3.7 (0.6) 4.0 (0.4) 3.3 (0.6) 4.1 (0.4)
L Hippocampus (cm3)g 3.5 (0.5) 3.5 (0.5) 3.6 (0.4) 3.1 (0.5) 3.8 (0.4)
Values represent means unless otherwise indicated. Standard deviations presented in parentheses
aMCI Mild Cognitive Impairment, amnestic type, naMCI Mild Cognitive Impairment, non-amnestic type, AD Alzheimer’s disease, HVLT-R Hopkins Verbal Learning
Test-Revised, raw score, BVMT-R Brief Visuospatial Memory Test-Revised, raw score
aAD > Normal Memory (p < .005).
bNormal Memory > non-amnestic MCI > amnestic MCI > AD
cNormal Memory > non-amnestic MCI > amnestic MCI > AD
dNormal Memory = non-amnestic MCI > amnestic MCI > AD
eNormal Memory = non-amnestic MCI > amnestic MCI > AD
fNormal Memory = non-amnestic MCI > amnestic MCI > AD
gNormal Memory > amnestic MCI = non-amnestic MCI > AD
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segmented, with each region identified by a distinctive
color [37] (see Fig. 1).
Visual inspection of the anatomical images was per-
formed to ensure good image quality and absence of not-
able artifacts. Additionally, review of the color-coded
images was performed for each subject to ensure quality
of hippocampal segmentation. Hippocampal segmentation
quality was graded as excellent, adequate or poor, depend-
ing on the presence and degree of any segmentation er-
rors. Failure of analysis (in rare instances) was due to
faulty registration, either due to severe motion or severe
volume loss (marked ventricular dilatation). Subjective as-
sessment of segmentation quality was used by visual in-
spection of the color coded images for color mismatch.
Although volumetric values of various brain regions
were calculated, only volumes of the right and left
hippocampus were extracted for the purposes of these
analyses (see Fig. 2).
In-house developed software was used to calculate the
total brain volume and percent of the intracranial volume.
Intracranial volume was calculated based on total brain
volume and hippocampal volume as a percentage of total
Fig. 1 Example output of the NeuroQuant computer-automated analysis, including volumetric information and segmented brain images
Fig. 2 Coronal image of NeuroQuant output, with arrows pointing
to the hippocampus
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intracranial volume. Certain volumetric measures were in-
cluded in the clinical reports for all participants. A state-
ment about study and segmentation qualities was
included in the report. Quality was graded subjectively as
adequate, marginal, or poor. All data were pooled into the
Cleveland Clinic’s Knowledge Project database, among
other clinical and neuropsychological data, where pertin-
ent data were retrieved according to the study protocol.
Data analysis
Data were analyzed to examine relationships between per-
formance on the episodic memory measures and hippo-
campal volumes. Partial correlations were conducted to
account for patient age, patient sex, and total intracranial
volume, as both factors are significantly associated with
hippocampal volumes. Fisher’s r-to-z transformations were
used to compare magnitudes of correlations (e.g., across
hemisphere, across clinical groups, etc.). Initial analyses
included the entire participant sample, while subsequent
analyses targeted individual diagnostic groups (i.e., amnes-
tic MCI, AD). Variables of interest for the memory mea-
sures included performance on individual learning trials,
total three-trial learning, learning over trials (i.e., differ-
ence between Trial 1 and Trial 3), delayed recall, and per-
cent retention (i.e., Delayed Recall/Trial 3).
Results
Demographic, behavioral, and volumetric data
Descriptive data for demographic, behavioral, and volu-
metric variables are presented in Table 1. Among the spe-
cific diagnostic groups, the AD group was significantly
older than the Normal Memory group. No other between-
group differences were found for age or any of the other
demographic variables (i.e., education, sex, handedness).
Next, diagnostic groups were compared to assess for
between-group differences on the behavioral variables.
Results of one-way analyses of variance (ANOVAs) indi-
cated significant between-group differences on all behav-
ioral variables (all p’s < .001), and post-hoc comparisons
were conducted. On both HVLT-R Learning and HVLT-
R Recall, the Normal Memory group performed signifi-
cantly better than all other diagnostic groups, and the
non-amnestic MCI group performed better than the
amnestic MCI and AD groups, while the amnestic MCI
group performed better than only the AD group. On
both BVMT-R Learning and BVMT-R Recall, the
Normal Memory and non-amnestic MCI groups did not
significantly differ from each other, while both per-
formed better than the amnestic MCI and AD groups.
In turn, the amnestic MCI group performed significantly
better than the AD group.
Diagnostic groups were then compared to assess for
between-group differences in hippocampal volumes.
Results of one-way ANOVAs indicated significant
between-group differences in both left and right hip-
pocampal volumes (p’s < .001). For right hippocampus,
post-hoc comparisons revealed that the Normal Mem-
ory and non-amnestic MCI groups were equivalent,
and both had larger volumes than the amnestic MCI
and AD groups. In turn, the amnestic MCI group had
larger volumes than the AD group. For left hippocam-
pus, the Normal Memory and non-amnestic groups did
not significantly differ from each other. The Normal
Memory group had larger volumes than the amnestic
MCI group, while the amnestic MCI and non-amnestic
MCI groups did not differ, and all groups had larger vol-
umes than the AD group.
Tests of normality revealed that many of the behavioral
and volumetric variables were not normally distributed
(i.e., HVLT-R Delayed Recall, BVMT-R Learning, BVMT-R
Delayed Recall, HVLT-R Retention and Learning over
Trials, BVMT-R Retention and Learning over Trials,
right hippocampal volumes). As such, we conducted
log transformations on all behavioral and hippocampal
volume data, and the analyses on the transformed
variables are presented below.
Correlational analyses – entire sample
Total learning and delayed recall
Significant positive correlations were found between
learning and recall on both HVLT-R and BVMT-R
and volumes of left and right hippocampus (Table 2).
Using Fisher’s r-to-z transformation to compare the
correlations, we found that the magnitude of the cor-
relations did not differ as a function of hemisphere.
Learning over trials
Correlations between hippocampal volumes and learn-
ing over trials indicated a specific positive relationship
between non-verbal learning and hippocampal volumes
(Table 3). Specifically, learning over trials on the BVMT-R
was significantly positively associated with volumes of
Table 2 Correlations between learning and recall performance and hippocampal volumes for the entire sample
HVLT-R – Total learning HVLT – Recall BVMT-R – Total learning BVMT-R – Recall
R Hippocampus .232* .302** .278** .343**
L Hippocampus .326** .316** .289** .328**
BVMT-R Brief Visuospatial Memory Test-Revised, HVLT-R Hopkins Verbal Learning Test-Revised
*p < .005
**p < .001
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both left and right hippocampus. In contrast, no such rela-
tionships were found between the HVLT-R and left or
right hippocampus, although the relationship between
HVLT-R learning over trials and right hippocampal vol-
umes reached trend-level significance (p = .06). Again, the
magnitude of the correlations did not differ as a function
of hemisphere.
Retention
Associations between retention over delay periods and
hippocampal volumes were assessed next (Table 3).
Percent retention for the HVLT-R was significantly posi-
tively associated with volume of hippocampus bilaterally.
Similarly, significant positive associations were found
between BVMT-R retention and hippocampal volumes bi-
laterally. The magnitudes of the correlations did not differ
as a function of hemisphere.
Correlational analyses – amnestic MCI group
Total learning and delayed recall
We next analyzed the data separately for the amnestic
MCI group (n = 82). We found evidence for a specific
positive relationship between non-verbal memory per-
formance and hippocampal volumes in this group
(Table 4). Specifically, we detected significant positive
correlations between BVMT-R total learning and delayed
recall and hippocampal volumes bilaterally. The magni-
tudes of the correlations did not significantly differ by
hemisphere. In contrast, no significant associations were
detected between HVLT-R total learning or delayed
recall and hippocampal volumes. Examination of the
correlation coefficients revealed that the relationship
between BVMT-R total learning and right hippocampal
volume was significantly higher than the relationship
between HVLT-R total learning and right hippocampal
volume (p < .05). No other correlation coefficients dif-
fered significantly across tasks.
Learning over trials and retention
We next investigated the relationship between hippo-
campal volumes and both learning over trials and per-
cent retention on both memory measures (Table 5).
None of the correlations reached statistical significance.
However, the relationships between right hippocampal
volume and both BVMT-R learning over trials (p = .075)
and BVMT-R retention (p = .056) were significant at a
trend level. The relationship between HVLT-R retention
and left hippocampal volume also reached trend-level
significance (p = .063).
Correlational analyses – additional subgroups
For purposes of comparison, we examined a subgroup
of patients with intact memory performance (n = 25), as
well as patients characterized as non-amnestic Mild
Cognitive Impairment (n = 13). We found that none of
the correlations between learning or recall measures
and hippocampal volumes reached significance for either
BVMT-R or HVLT-R in either group. In fact, many of the
associations were negative.
We also examined a subgroup of patients diagnosed
with probable Alzheimer’s disease (n = 34). Again, none
of the correlations between memory measures and hip-
pocampal volumes reached significance.
Discussion
In the current study, we examined associations between
hippocampal volumes and memory performance in a large,
heterogeneous memory clinic sample, using commonly-
used memory measures and an FDA-approved auto-
mated neuroimaging analysis tool. Within this context,
there were a number of main findings. The sample as a
whole showed significant positive correlations between
bilateral hippocampal volumes and both verbal and
non-verbal memory measures. Additionally, the BVMT-R
showed more positive associations with hippocampal vol-
umes than indices on the HVLT-R. In the amnestic MCI
group, we found further evidence of a specific positive as-
sociation between non-verbal memory performance and
hippocampal volumes bilaterally. Additionally, we found
evidence of material-specific (i.e., verbal vs. non-verbal)
lateralization in the amnestic MCI group, although these
findings did not reach statistical significance. We describe
each of these main findings below.
Entire sample
The full sample showed significant positive associations
between hippocampal volumes and performance on epi-
sodic memory measures. Consistent with previous work
in this area [9–12, 18], indices of memory performance
(i.e., total learning, percent retention, and delayed recall)
Table 3 Correlations between learning over trials and retention and hippocampal volumes for the entire sample
HVLT-R – LOT HVLT-R – Retention BVMT-R – LOT BVMT-R - Retention
R Hippocampus .13 .30** .23** .23*
L Hippocampus .11 .29** .22* .23*
HVLT-R, Hopkins Verbal Learning Test-Revised, LOT Learning over trials (i.e., Trial 3 – Trial 1), BVMT-R Brief Visuospatial Memory Test-Revised
Retention = Percent of information initially learned that is spontaneously recalled at Delayed Recall (i.e., Delay/Trial 3)
**p < .001
*p < .005
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on both the verbal and non-verbal measures were signifi-
cantly positively correlated with volumes of hippocampus
bilaterally. These findings confirm the association between
hippocampal integrity and performance on episodic mem-
ory measures typically administered in an outpatient
memory clinic.
Contrary to our predictions, we did not find evi-
dence of material-specific lateralization with regard to
relationships between hippocampal volumes and memory
performance, as the strength of the relationships did not
differ as a function of hemisphere. The reasons for this are
unclear, as some researchers who have examined this ques-
tion in individuals with AD have reported lateralization
effects [15, 24]. It is possible that analysis of the full hetero-
geneous sample (rather than just the AD group) affected
the outcome, although our analysis of the AD patients
alone did not yield evidence of lateralization. Second, the
differences in findings across studies also may reflect differ-
ences in the memory tasks used, as the tasks in the current
study did not overlap with those in which lateralization
effects were found. Lastly, one such study [15] found lat-
erality effects in the right parahippocampal gyrus, whereas
we restricted our analyses to the hippocampus. Thus, it is
possible that we would have detected laterality effects had
we examined more structures in the mesial temporal lobes.
Across the whole sample, therefore, hippocampal vol-
umes showed significant positive relationships with
memory measures in both modalities. However, learning
over trials on the BVMT-R was significantly positively
associated with volumes of both left and right hippo-
campus, while no such relationship was detected for the
HVLT-R. Although the magnitudes of the correlations
did not significantly differ, non-verbal learning over trials
(or “learning curve”) appears to be somewhat more sen-
sitive to hippocampal integrity in a manner that is not
seen as prominently for verbal learning.
Previous studies of MCI and AD generally have em-
phasized deficits in verbal learning [38–41], and associa-
tions between verbal episodic memory performance and
hippocampal volumes in individuals with MCI have been
reported [42]. However, the current findings indicate
that examination of the learning curve for non-verbal in-
formation also should be considered and may provide
valuable information regarding potential degenerative
changes. In accord with our findings, increasing evi-
dence suggests a role for non-verbal memory measures,
including rate of learning, in differential diagnosis of older
adults with memory dysfunction [29, 30], as well as pre-
diction of decline and development of AD [31–33]. Our
results extend these findings by demonstrating an associ-
ation between non-verbal memory (including learning
over trials) and a commonly-used biomarker of AD. Relat-
edly, most clinical trials of AD therapies have used only
verbal measures in assessment of memory. Our findings
suggest that inclusion of non-verbal memory measures
will be an important consideration for future trials. It is
possible that inherent properties of BVMT-R make it a
strong tool in measuring memory function in a dementia
clinic setting. For example, participants are scored on both
accuracy of form and accuracy of location of their draw-
ings. As such, the emphasis on spatial memory and the
necessity of binding form with location may make the
BVMT-R a more rigorous measure of hippocampal integ-
rity than verbal measures.
Amnestic MCI subgroup
Similar to the whole-group findings, analyses among in-
dividuals with amnestic MCI revealed significant positive
associations between bilateral hippocampal volumes and
both total learning and delayed recall on BVMT-R, while
no such relationships were detected for the HVLT-R.
Additionally, the correlation between BVMT-R total
Table 4 Correlations between learning and recall performance and hippocampal volumes for the amnestic MCI group
HVLT-R – Total learning HVLT-R – Recall BVMT-R – Total learning BVMT-R - Recall
R Hippocampus .01 .12 .34*** .30**
L Hippocampus .10 .19 .27* .23*




Table 5 Correlations between learning over trials and retention and hippocampal volumes for the amnestic MCI group
HVLT-R – LOT HVLT-R – Retention BVMT-R – LOT BVMT-R - Retention
R Hippocampus -.03 .17 .20 .22
L Hippocampus -.02 .22 .09 .20
MCI Mild cognitive impairment, HVLT-R, Hopkins Verbal Learning Test-Revised, LOT Learning over trials (i.e., Trial 3 – Trial 1), BVMT-R Brief Visuospatial
Memory Test-Revised
Retention = Percent of information initially learned that is spontaneously recalled at Delayed Recall (i.e., Delay/Trial 3)
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learning and right hippocampal volume was significantly
larger than the correlation between HVLT-R total learning
and right hippocampal volume. These results highlight the
utility of non-verbal memory measures in dementia as-
sessment, particularly for those at the MCI stage. To our
knowledge, few (if any) studies have examined this issue
in those with amnestic MCI, which represents a high-risk
group for development of AD. This finding also has sig-
nificant clinical implications, as it provides useful informa-
tion regarding neuropsychological measures that may best
predict conversion to AD in those with MCI.
Additional analysis of the data for the amnestic MCI
group revealed trend-level evidence of material-specific
lateralization. Specifically, we found a positive associ-
ation between left hippocampal volumes and HVLT-R
retention (p = .063), as well as positive relationships be-
tween right hippocampal volumes and BVMT-R learning
curve (p = .075) and retention (p = .056). While not sta-
tistically significant, our findings somewhat resemble
those of Jones-Gotman [43], who found that left MTL
seizures were associated with impaired verbal recall,
while right MTL seizures were associated with impaired
non-verbal learning. Kennepohl and colleagues [44] re-
ported similar findings among healthy control partici-
pants. This finding may suggest a division of labor
within the MTL with regard to memory processes and
supports the value of both verbal and non-verbal mem-
ory measures in the assessment of those at risk for AD.
As noted above, however, these findings did not reach
statistical significance and should be interpreted cau-
tiously. Future studies are required to further evaluate
this issue in individuals with amnestic MCI.
Given previous findings in the literature, it was some-
what surprising that no significant associations were de-
tected in the probable AD group, although lack of power
due to smaller sample size may have contributed to this
finding. Restriction of range in hippocampal size and/or
memory performance also may have limited our ability
to detect significant relationships in the AD group.
Nevertheless, these results suggest an important role for
non-verbal memory measures in assessing individuals
with amnestic MCI.
Overall, strengths of the current study include use
of a large, heterogeneous sample of patients typically
seen in a dementia clinic within an academic medical
center. Our patients were well-characterized with re-
gard to cognitive performance and underwent full
neuropsychological batteries, including memory mea-
sures that are commonly used in dementia clinics and
are co-normed with each. Neuroimaging data were
analyzed with FDA-approved software (NeuroQuant)
that automatically segmented and quantified hippo-
campal volumes. Samples of this size that include
both neuroimaging and thorough cognitive evaluation
are rare in studies in this area. Additionally, we were
able to include a large subset of individuals with
amnestic MCI to examine those who are at elevated
risk for development of AD.
Limitations
As mentioned previously, smaller sample sizes in the
other diagnostic groups, relative to the amnestic MCI
group, may have limited our ability to find significant
associations. Replication of these findings with larger
sample sizes is, therefore, warranted. Use of multiple
correlational analyses also increased our risk of Type I
(i.e., false positive) errors. However, the vast majority of
associations showed moderate effect sizes, reducing the
likelihood that they were spurious. Additionally, it
should be noted that output of the NeuroQuant program
includes volumes of many other brain structures (e.g.,
thalamus, amygdala, caudate, putamen, etc.). However,
given its central role in the development of Alzheimer’s
disease, we chose to restrict our analyses only to the
hippocampus. Examination of the relationship between
volumes of other brain regions and episodic memory per-
formance will be an area of future study.
Conclusions
Taken together, our findings indicate significant posi-
tive associations between volumes of the hippocampus
bilaterally and memory function in our memory clinic
sample, with evidence to suggest that the learning
curve on a non-verbal memory measure represents a
key marker of hippocampal integrity. Among individ-
uals with amnestic MCI, a specific association was
identified between non-verbal learning and recall perform-
ance and bilateral hippocampal volumes. We also found
trend-level evidence of material-specific lateralization,
such that retention of verbal information was positively
associated with left hippocampal volume, whereas learning
curve and retention of non-verbal information was posi-
tively associated with right hippocampal volume.
There is increasing consensus supporting the use of
multiple markers, including neuropsychological mea-
sures and hippocampal volumes, in diagnosis and pre-
diction of disease course in neurodegenerative disorders
[26, 45–47]. We provide evidence to support the link be-
tween performance on episodic memory measures and
hippocampal volumes in a memory clinic population,
and we assert that measures of non-verbal memory may
have higher diagnostic value, particularly in individuals
at higher risk for development of AD (i.e., amnestic
MCI), which represents a target for future research.
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